Kidney transplantation is the kidney replacement
therapy method with the highest probability of restoring reproductive potential
in women with advanced chronic kidney disease. Following a successful
transplant, ovulatory cycles and spontaneous fertility often return within the
first few months, frequently within the first six months; this makes pregnancy
a realistic possibility for many women who were subfertile during dialysis or
in the course of advanced renal failure. However, pregnancy should never be considered
a routine occurrence in kidney transplant recipients. Pregnancy is a high-risk
clinical situation, carrying not only the physiological burden of pregnancy
itself but also the combined effects of chronic kidney disease, a single
functioning graft, the need for lifelong immunosuppression, and the associated
disease burden of hypertension, proteinuria, and the risk of infection. Despite all these challenges, current data are
generally encouraging with careful planning. Data from registry systems and
meta-analyses show that live births are possible in the majority of pregnancies
following kidney transplantation, with live birth rates often ranging from
approximately 73–79%. These findings demonstrate that successful motherhood is
possible in this patient group. However, despite acceptable live birth rates,
rates of hypertensive pregnancy disorders, preterm birth, cesarean section, and
fetal growth restriction are significantly higher compared to the general
obstetric population. Therefore, the primary goal of care is not only to allow
pregnancy but also to ensure conception occurs at the safest possible time and
under the most appropriate clinical conditions.
Atıf Sayısı :